Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

CD4+ T cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm.
Methods for Ex Vivo Analysis of Immune Cell Function from the Central Nervous System.
Intracortical Posterior Cingulate Myelin Content Relates to Error Processing: Results from T1- and T2-Weighted MRI Myelin Mapping and Electrophysiology in Healthy Adults.
Integrin-linked kinase regulates oligodendrocyte cytoskeleton, growth cone, and adhesion dynamics.
Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder.
Cost Effectiveness Analysis of Avonex and CinnoVex in Relapsing Remitting MS.
Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials.
Remote control-triggering of brain autoimmune disease in the gut.
Regulatory Lymphocytes Are Key Factors in MHC-Independent Resistance to EAE.
Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice.
A peptide nucleic acid (PNA)-mediated polymerase chain reaction clamping allows the selective inhibition of the ERVWE1 gene amplification.
Multiple Sclerosis between Genetics and Infections: Human Endogenous Retroviruses in Monocytes and Macrophages.
Screening, Synthesis, and In Vitro Evaluation of Vinyl Sulfones as Inhibitors of Complement-Dependent Cytotoxicity in Neuromyelitis Optica.
Fatigue in multiple sclerosis is closely related to sleep disorders: a polysomnographic cross-sectional study.
Dysfunction in Motor Coordination in Neonatal White Matter Injury Model without Apparent Neuron Loss.
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis.
Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis.
Vitamin D3 Induces IDO(+) Tolerogenic DCs and Enhances Treg, Reducing the Severity of EAE.
Development and validation of the actionable bladder symptom screening tool for multiple sclerosis patients.
A pilot, longitudinal, 24-week study to evaluate the effect of interferon beta-1a subcutaneous on changes in susceptibility-weighted imaging-filtered phase assessment of lesions and subcortical deep-gray matter in relapsing-remitting multiple sclerosis.
Human recombinant domain antibodies against multiple sclerosis antigenic peptide CSF114(Glc).
Minimal supportive treatment in natalizumab-related PML in a MS patient.
Distal acquired demyelinating symmetric neuropathy associated with colorectal adenocarcinoma: Should it be termed paraneoplastic?
Sphingosine 1-phosphate signaling at the blood-brain barrier.
Targeting endothelial CD146 attenuates neuroinflammation by limiting lymphocyte extravasation to the CNS.

Pages